HDAC9 and cancer: However, some studies have shown that relatively few (approximately 10%) genes in cancer cell lines—such as leukemia, multiple myeloma and carcinomas of colon, bladder, kidney, prostate and breast, cultured for up to 48h with TSA, SAHA and other HDAC inhibitors—are directly altered in their expression [13].